Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.
 

Mediterranean diet keto diet

Keto diet could be good for heart failure patients, but many questions remain

A team of specialists from the Cleveland Clinic detailed the potential benefits—and risks—associated with following a ketogenic diet to address heart failure symptoms. The group recommended borrowing heavily from the Mediterranean diet and avoiding heavily processed "keto-friendly" products. 

July 13, 2023
Sen. Chunk Schumer has asked the U.S. Food and Drunk Administration (FDA) to investigate the high amount of caffeine found in energy drinks sold by Prime, a beverage brand founded by YouTube personalities Logan Paul and KSI. According to Schumer, the “eye-popping 200 mg of caffeine” found in a single Prime energy drink is troubling, especially for a product marketed primarily to children.

FDA asked to investigate ‘eye-popping’ amount of caffeine in Logan Paul’s Prime energy drinks

Should an energy drink with more caffeine than five cans of soda be marketed to kids? Sen. Chunk Schumer shared his concerns in a new letter to FDA Commissioner Robert Califf, MD, a veteran cardiologist. 

July 11, 2023
The FDA has approved donislecel, a new pancreatic islet cellular therapy made from the pancreatic cells of deceased donors, for the treatment of type 1 diabetes among adult patients with severe hypoglycemia. Lantidra

FDA approves first cellular therapy to treat type 1 diabetes

The new therapy, made from the pancreatic cells of deceased donors, is designed to help adult type 1 diabetes with severe hypoglycemia go a year or longer without needing to take insulin. 

June 29, 2023
Money dollar investments

Abbott awards $2.6M to American Diabetes Association for CGM research

The three-year grant will help the ADA fund two pilot programs and engage with healthcare professionals and other industry leaders.

June 26, 2023
The U.S. Food and Drug Administration (FDA) priority review, the FDA has cleared the Agepha Pharma USA LLC's drug Lodoco (colchicine) as the first anti-inflammatory atheroprotective cardiovascular treatment. Colchicine prevents coronary artery plaque inflammation, heart inflammation. Colchicine for coronary artery disease. Colchicine for coronary inflammation FDA Approves Colchicine for Decreasing CV Events FDA Approves Colchicine for decreasing inflammation caused by coronary atherosclerosis.

FDA approves colchicine, the first anti-inflammatory drug for treating cardiovascular disease

The FDA's approval of colchicine, which is marketed and sold under the name Lodoco, is expected to have a big impact on cardiac care and outcomes.

June 20, 2023

Novo Nordisk close to acquiring French medical device company for $165M

The two companies first started collaborating on diabetes technology in 2021. The acquisition is not yet final, but Novo Nordisk now holds the exclusive negotiation rights.

June 5, 2023
approved approval

FDA approves sotagliflozin, the new heart failure drug from Lexicon Pharmaceuticals

The drug, which should be available by the end of June, will be marketed under the name Inpefa.

May 30, 2023
Business newspaper

Medtronic acquires insulin patch manufacturer for $738M

The deal represents a significant step forward for Medtronic's diabetes portfolio.

May 25, 2023

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Trimed Popup
Trimed Popup